Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site software/version release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded a link to the Genetic and Rare Diseases Information Center as a resource and included the 'Gastric cancer' term; removed the funding-status notice and an older revision note.SummaryDifference0.5%

- Check100 days agoChange DetectedAdded a site-wide notice about government funding and NIH operations. Updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.